NSE filing, NSE: SATKARTAR. Summary written from the filing by ALFA Finder's alert engine.
Sat Kartar Life Ltd: key numbers
- Share price
- ₹130.00
- Market cap
- ₹205.3 Cr
- Revenue (annual)
- ₹200.7 Cr
- Net profit (annual)
- ₹17.10 Cr
- P/E (TTM)
- 12.0×Sector 45.9×
- Promoter holding
- 63.49%
- FII holding
- 0.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sat Kartar Life Ltd
All →Sat Kartar Life Earnings Call Transcript: Key Takeaways
Sat Kartar Life is pivoting from pure Ayurveda products to an integrated healthcare model, showing strong revenue growth but scaling back prior top-line guidance to prioritize margins.
- Call
- Guides 32% growth
Sat Kartar Life H1 FY27 Results: Net Profit ₹9.2 Cr, Up 26.0% YoY
Sat Kartar Life Ltd reported revenue from operations of ₹113.9 Cr (+26.4% YoY) and net profit of ₹9.2 Cr (+26.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹9.2 Cr · +26.0% YoY
Sat Kartar Life Investor Presentation: Key Takeaways
H1 FY27 deck discloses no revenue, PAT or EBITDA figures. Balance sheet is debt-free with ₹18.7 Cr net cash. Growth is hospital-led: 30-bed Delhi unit at breakeven, 300 beds targeted by FY27-end.
Sat Kartar Life Results Update
Sat Kartar Life Limited reported H1 FY27 revenue growth of 26% and EBITDA growth of 48% via press release. Its first Ayurveda hospital reached operating breakeven.
Sat Kartar Life Other Announcement
Sat Kartar Life filed CARE Ratings' IPO proceeds monitoring report for half year ended September 2026. It shows nil deviation from objects, so no new event occurred.
Sat Kartar Life Convertible Warrants
Sat Kartar Life's EGM covered one special resolution to issue fully convertible warrants to promoter group on preferential basis. Voting results follow within two working days.
Other regulatory approval announcements
All →Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031
360 One Wam Regulatory Approval
360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.
Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.